|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-26
|
|
pubmed:abstractText |
Most of the patients with pulmonary arterial hypertension (PAH) receiving intravenous epoprostenol have experienced catheter-related infections during long-term treatment. Catheter hub was reported to be the most important source of catheter-related infections. To prevent the catheter-related infections, we have introduced a closed hub system and compared the incidence of catheter-related infections with that in patients using a non-closed hub system.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1346-9843
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
559-64
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17384460-Adolescent,
pubmed-meshheading:17384460-Adult,
pubmed-meshheading:17384460-Antihypertensive Agents,
pubmed-meshheading:17384460-Bacterial Infections,
pubmed-meshheading:17384460-Catheterization, Central Venous,
pubmed-meshheading:17384460-Catheters, Indwelling,
pubmed-meshheading:17384460-Epoprostenol,
pubmed-meshheading:17384460-Equipment Contamination,
pubmed-meshheading:17384460-Female,
pubmed-meshheading:17384460-Humans,
pubmed-meshheading:17384460-Hypertension, Pulmonary,
pubmed-meshheading:17384460-Kaplan-Meier Estimate,
pubmed-meshheading:17384460-Male,
pubmed-meshheading:17384460-Middle Aged,
pubmed-meshheading:17384460-Pulmonary Artery
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension.
|
|
pubmed:affiliation |
Division of Cardiology, National Hospital Organization Okayama Medical Center, Okayama, Japan. sakagi-circ@umin.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
